Vijaya Diagnostic Centre Limited (BOM: 543350)
India
· Delayed Price · Currency is INR
1,039.70
-20.00 (-1.89%)
At close: Dec 20, 2024
Vijaya Diagnostic Centre Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
Revenue | 6,271 | 5,478 | 4,592 | 4,624 | 3,767 | 3,388 | Upgrade
|
Revenue Growth (YoY) | 26.93% | 19.29% | -0.68% | 22.73% | 11.19% | 15.80% | Upgrade
|
Cost of Revenue | 974.83 | 863.73 | 764.66 | 847.93 | 673.34 | 554.24 | Upgrade
|
Gross Profit | 5,296 | 4,614 | 3,828 | 3,776 | 3,094 | 2,834 | Upgrade
|
Selling, General & Admin | 1,111 | 985.79 | 846.63 | 758.93 | 612.4 | 692.05 | Upgrade
|
Other Operating Expenses | 1,658 | 1,420 | 1,161 | 979.87 | 818.65 | 815.14 | Upgrade
|
Operating Expenses | 3,413 | 2,975 | 2,624 | 2,266 | 1,939 | 1,999 | Upgrade
|
Operating Income | 1,883 | 1,639 | 1,203 | 1,510 | 1,155 | 834.51 | Upgrade
|
Interest Expense | -229.61 | -219.62 | -194.25 | -152.15 | -135.09 | -133.32 | Upgrade
|
Interest & Investment Income | 59.73 | 59.73 | 82.8 | 97.99 | 95.96 | 42.63 | Upgrade
|
Other Non Operating Income (Expenses) | -60.49 | -16.65 | -13.58 | -9.32 | -16.72 | -18.7 | Upgrade
|
EBT Excluding Unusual Items | 1,653 | 1,462 | 1,078 | 1,447 | 1,099 | 725.12 | Upgrade
|
Gain (Loss) on Sale of Investments | 124.76 | 124.76 | 47.19 | 18.39 | 4.86 | 65.83 | Upgrade
|
Gain (Loss) on Sale of Assets | 19.52 | 19.52 | 0.86 | 3.98 | 1.56 | 33.13 | Upgrade
|
Other Unusual Items | -19.95 | -19.95 | 9 | 2.14 | 15.44 | 7.35 | Upgrade
|
Pretax Income | 1,777 | 1,587 | 1,135 | 1,474 | 1,121 | 834.27 | Upgrade
|
Income Tax Expense | 444.13 | 390.44 | 283.03 | 367.17 | 269.97 | 209.2 | Upgrade
|
Earnings From Continuing Operations | 1,333 | 1,196 | 852.07 | 1,107 | 851.27 | 625.07 | Upgrade
|
Minority Interest in Earnings | -7.28 | -8.12 | -5.75 | -9.87 | -6.48 | 0.31 | Upgrade
|
Net Income | 1,326 | 1,188 | 846.32 | 1,097 | 844.78 | 625.38 | Upgrade
|
Net Income to Common | 1,326 | 1,188 | 846.32 | 1,097 | 844.78 | 625.38 | Upgrade
|
Net Income Growth | 28.24% | 40.40% | -22.84% | 29.83% | 35.08% | 36.33% | Upgrade
|
Shares Outstanding (Basic) | 102 | 102 | 102 | 102 | 102 | 102 | Upgrade
|
Shares Outstanding (Diluted) | 103 | 103 | 102 | 103 | 102 | 102 | Upgrade
|
Shares Change (YoY) | 0.19% | 0.04% | -0.08% | 0.57% | -0.02% | 0.02% | Upgrade
|
EPS (Basic) | 12.95 | 11.62 | 8.29 | 10.76 | 8.28 | 6.13 | Upgrade
|
EPS (Diluted) | 12.91 | 11.59 | 8.26 | 10.69 | 8.28 | 6.13 | Upgrade
|
EPS Growth | 27.97% | 40.31% | -22.73% | 29.11% | 35.07% | 36.22% | Upgrade
|
Free Cash Flow | 1,361 | 953.37 | 397.69 | 356.5 | 975.06 | 585.65 | Upgrade
|
Free Cash Flow Per Share | 13.25 | 9.30 | 3.88 | 3.48 | 9.56 | 5.74 | Upgrade
|
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | - | - | Upgrade
|
Gross Margin | 84.45% | 84.23% | 83.35% | 81.66% | 82.13% | 83.64% | Upgrade
|
Operating Margin | 30.03% | 29.92% | 26.20% | 32.66% | 30.66% | 24.63% | Upgrade
|
Profit Margin | 21.14% | 21.69% | 18.43% | 23.72% | 22.42% | 18.46% | Upgrade
|
Free Cash Flow Margin | 21.70% | 17.40% | 8.66% | 7.71% | 25.88% | 17.28% | Upgrade
|
EBITDA | 2,248 | 1,930 | 1,581 | 1,846 | 1,491 | 1,176 | Upgrade
|
EBITDA Margin | 35.84% | 35.24% | 34.44% | 39.92% | 39.57% | 34.71% | Upgrade
|
D&A For EBITDA | 364.33 | 291.19 | 378.31 | 335.58 | 335.67 | 341.49 | Upgrade
|
EBIT | 1,883 | 1,639 | 1,203 | 1,510 | 1,155 | 834.51 | Upgrade
|
EBIT Margin | 30.03% | 29.92% | 26.20% | 32.66% | 30.66% | 24.63% | Upgrade
|
Effective Tax Rate | 24.99% | 24.61% | 24.93% | 24.91% | 24.08% | 25.08% | Upgrade
|
Revenue as Reported | 6,435 | 5,686 | 4,734 | 4,752 | 3,886 | 3,542 | Upgrade
|
Advertising Expenses | - | 35.51 | 23.78 | 29.17 | 17.64 | 20.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.